BORN TO DISCOVER
25+ YEAR HISTORY
We are the only biopharmaceutical company led by physician-scientists for our entire, nearly 30-year history. From our first days, science was and remains our central guiding principle. We continue to invest in groundbreaking technologies and research, and employ strategies that enable our scientists to consistently explore new paths.
We are focused on addressing a broad range of serious medical conditions including ophthalmology, cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. Our industry-leading research and development engine enables us to develop all potential drug candidates from within our own labs.
Our strategy is to follow the science, rather than limiting our innovations to any one therapeutic area. We are focused on solving the human body's most complex mysteries — from ophthalmology to cancer to inflammation to pain to cardiovascular disease. This includes twelve antibodies currently in clinical trials.
TECHNOLOGY THAT BREAKS BOTTLENECKS
Our core capabilities for target discovery and validation are enabled by a series of Regeneron-invented technologies that accelerate, improve and disrupt the traditional drug discovery and development process. Collectively, these technologies represent some of the most valuable biotechnologies ever created, and aid our efforts to continuously accelerate the average timeline from discovery to drug approval.
UNITED IN DISCOVERY
Along with our distinguished collaborators, we are uncovering cutting-edge scientific advances. Partner with our researchers and help turn science into life-changing medicine.